跳至主要内容
临床试验/NL-OMON31525
NL-OMON31525已完成3 期

A randomized long-term safety study of Org 50081 in elderly outpatients with chronic primary insomnia examining the effects of 1.5 mg or 3.0 mg of Org 50081 - JADE

Organon Nederland BV0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • At least 65 years of age at screening.;Have documented diagnosis of chronic primary insomnia with a duration of >_ 1 month.;Are able to speak, read and understand the language of the investigator, study
  • staff (including raters) and the informed consent form, and possess the ability to
  • respond to questions, follow instructions and complete questionnaires.;Have demonstrated capability to independently complete the LogPad
  • questionnaires in the week preceding randomization;

排除标准

  • have other sleep disorders;have any significant medical or psychiatric illness causing sleepdisturbances;have any significant medical or DSM-IV-TR psychiatric illness causing the sleep
  • disturbances;;currently meet diagnostic criteria for DSM-IV-TR depression (MDD) or have been
  • diagnosed and treated for MDD within the last 2 years;;have signs of dementia or other serious cognitive impairment, defined by a score
  • of less than 26 on the Mini-Mental State Examination (MMSE);;have a history of bipolar disorder, a history of suicide attempt or a family history
  • of suicide;

研究者

发起方
Organon Nederland BV

相似试验